Hormonal IUDs Market

Hormonal IUD, sold under the brand name Mirena among others, is an intrauterine device that releases the hormone levonorgestrel into the uterus. It is used for birth control, heavy menstrual periods, and to prevent excessive build of the lining of the uterus in those on estrogen replacement therapy. It is one of the most effective forms of birth control with a one-year failure rate around 0.2%. The device is placed in the uterus and lasts three to seven years. Fertility often returns quickly following removal.

Hormonal IUDs Market contains market size and forecasts of Hormonal IUDs in global, including the following market information:

• Global Hormonal IUDs Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Hormonal IUDs Market Sales, 2017-2022, 2023-2028, (K Units)
• Global top five Hormonal IUDs companies in 2021 (%)

The global Hormonal IUDs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

13mg IUDs Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Hormonal IUDs include Bayer, Merck, Cooper Companies, AbbVie Allergan, Yantai JiShengYaoXie, H & J Medical and HRA Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hormonal IUDs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Hormonal IUDs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Hormonal IUDs Market Segment Percentages, by Type, 2021 (%)

• 13mg IUDs
• 19mg IUDs
• 52mg IUDs

Global Hormonal IUDs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Hormonal IUDs Market Segment Percentages, by Application, 2021 (%)

• Age 25-34
• Age 20-24
• Age 35-44
• Others

Global Hormonal IUDs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Hormonal IUDs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Hormonal IUDs revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Hormonal IUDs revenues share in global market, 2021 (%)
• Key companies Hormonal IUDs sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Hormonal IUDs sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Bayer
• Merck
• Cooper Companies
• AbbVie Allergan
• Yantai JiShengYaoXie
• H & J Medical
• HRA Pharma